Stephen Deventer - PreveCeutical Medical Chairman CEO

All Insiders . USA . 
Stock . PreveCeutical Medical . Stakeholders . Insider . Stephen Deventer
PRVCF Stock  USD 0.02  0  9.76%   

Insider

Stephen Deventer is Chairman CEO of PreveCeutical Medical
Age 54
Phone604 416 7777
Webhttps://www.preveceutical.com

PreveCeutical Medical Management Efficiency

The company has return on total asset (ROA) of (3.3124) % which means that it has lost $3.3124 on every $100 spent on assets. This is way below average. PreveCeutical Medical's management efficiency ratios could be used to measure how well PreveCeutical Medical manages its routine affairs as well as how well it operates its assets and liabilities.
PreveCeutical Medical has accumulated 1.68 M in total debt with debt to equity ratio (D/E) of 347.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PreveCeutical Medical has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist PreveCeutical Medical until it has trouble settling it off, either with new capital or with free cash flow. So, PreveCeutical Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PreveCeutical Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PreveCeutical to invest in growth at high rates of return. When we think about PreveCeutical Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Christopher GarciaSurrozen
N/A
Peter MBABio Path Holdings
76
Victoria RacBio Path Holdings
N/A
Hannah FryProtara Therapeutics
34
MS JDSurrozen
62
Jeffery MDBio Path Holdings
N/A
Samuel BerryFortress Biotech Pref
N/A
Jesse SheffermanProtara Therapeutics
53
MBA MPHProtara Therapeutics
41
WenChen MDSurrozen
60
Andrew MBAMonopar Therapeutics
53
Elizabeth NguyenSurrozen
N/A
Kristine RosseProtara Therapeutics
N/A
MBA MDSurrozen
56
Craig LewisBenitec Biopharma Ltd
N/A
Alan MacKenzieBio Path Holdings
N/A
Michael EsqFortress Biotech Pref
57
David JinFortress Biotech Pref
33
MBA MDMonopar Therapeutics
38
Roeland NusseSurrozen
75
Thomas SchaibleFortress Biotech Pref
N/A
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada. Preveceutical Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange. PreveCeutical Medical [PRVCF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Return On Asset-3.31

PreveCeutical Medical Leadership Team

Elected by the shareholders, the PreveCeutical Medical's board of directors comprises two types of representatives: PreveCeutical Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PreveCeutical. The board's role is to monitor PreveCeutical Medical's management team and ensure that shareholders' interests are well served. PreveCeutical Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PreveCeutical Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Makarand Jawadekar, Pres Officer
CGA CPA, CFO Controller
Stephen Deventer, Chairman CEO
Parekh BSc, Chief Officer

PreveCeutical Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is PreveCeutical Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset-3.31
Current Valuation12.06 M
Shares Outstanding523.3 M
Shares Owned By Insiders24.08 %
Price To Sales3,902 X
Gross Profit2.25 K
EBITDA(1.28 M)
Net Income(1.73 M)
Cash And Equivalents2.64 K
Total Debt1.68 M

Currently Active Assets on Macroaxis

FFord Motor
GMGeneral Motors
SSentinelOne
GOOGAlphabet Inc Class C
WDWalker Dunlop

Other Information on Investing in PreveCeutical OTC Stock

PreveCeutical Medical financial ratios help investors to determine whether PreveCeutical OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PreveCeutical with respect to the benefits of owning PreveCeutical Medical security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY